Oedema Formation: The Starling Forces in Disease

Hydrostatic vs oncotic pressure, lymphatic drainage, endothelial permeability, glycocalyx function, and the four pathophysiological categories of oedema with clinical veterinary examples for each.

Introduction: Why Water Leaves the Vessel

Under normal conditions, the capillary wall is a semipermeable barrier — it retains plasma proteins (albumin, globulins, fibrinogen) within the circulation while allowing water, electrolytes, and small solutes to filter through into the interstitium. The balance of forces governing this filtration — the Starling forces — keeps the interstitium 'just moist enough' for efficient diffusion of nutrients and waste products. When this balance is disrupted, the interstitium swells with excess fluid — oedema.

This article examines the physics of oedema formation through the lens of the revised Starling principle (the glycocalyx model), categorises oedema into four pathophysiological types, and provides clinical veterinary examples of each. Understanding WHY fluid is accumulating in a particular compartment is the first step to managing it effectively — not all oedema responds to furosemide.

The Four Pathophysiological Categories of Oedema

Category 1: Hydrostatic Oedema — When the Pressure Is Too High

Left-Sided Congestive Heart Failure → Pulmonary Oedema

The sequence: myocardial failure (DCM, mitral valve disease) → increased left ventricular end-diastolic pressure (LVEDP) → increased left atrial pressure → increased pulmonary venous pressure → increased pulmonary capillary hydrostatic pressure (P_c). When P_c exceeds ~25 mmHg (normal ~10 mmHg), the rate of fluid filtration exceeds the capacity of the pulmonary lymphatics to drain it → fluid accumulates in the pulmonary interstitium → when interstitial capacity is exceeded → fluid moves into the alveolar spaces → PULMONARY OEDEMA.

Stage 1 — Interstitial oedema: engorged pulmonary veins, Kerley B lines (interlobular septal thickening), peribronchial cuffing on radiographs. The patient is tachypnoeic but may not have crackles yet. Stage 2 — Alveolar oedema: fluffy, coalescing alveolar infiltrates (classic 'bat-wing' or perihilar pattern in dogs; more patchy in cats). Crackles on auscultation. Pink, frothy fluid may appear at the nares. This is a life-threatening emergency.

Right-Sided Congestive Heart Failure → Ascites and Peripheral Oedema

The same haemodynamic logic applies to the right heart: right ventricular failure → increased right atrial pressure → increased systemic venous pressure → hepatic congestion → increased hepatic sinusoidal pressure → fluid transudation across the hepatic capsule into the peritoneal cavity → ASCITES. In dogs, ascites is the hallmark of right-sided CHF (DCM, severe tricuspid regurgitation, pericardial effusion with tamponade). In cats, ascites is rare in CHF — cats preferentially develop pleural effusion because their pleural lymphatics have limited capacity. A cat with ascites more likely has FIP, neoplasia, or hepatic disease than right-sided CHF.

Category 2: Hypo-Oncotic Oedema — When the Proteins Are Missing

Albumin accounts for approximately 75% of plasma oncotic pressure. When the serum albumin falls below approximately 1.5–2.0 g/dL, the oncotic gradient (π_c − π_i) is insufficient to retain fluid within the capillaries, and oedema develops — typically in dependent areas (limbs, ventral abdomen) and body cavities (pleural effusion, ascites, or both).

Protein-losing enteropathy (PLE) in dogs: lymphangiectasia, inflammatory bowel disease, or intestinal lymphoma → loss of albumin (and globulins) into the GI lumen. Clinical signs: weight loss, diarrhoea, ascites, peripheral oedema. Diagnosis: serum albumin <2.0 g/dL, faecal alpha-1 proteinase inhibitor (α1-PI) concentration elevated, intestinal biopsy. Protein-losing nephropathy (PLN): glomerular disease (glomerulonephritis, amyloidosis) → loss of albumin (and antithrombin III) in urine → hypoalbuminaemia + hypercoagulability (loss of antithrombin III). Diagnosis: urine protein:creatinine ratio (UPCR) >2.0 (or >0.5 in cats), serum albumin <2.0 g/dL. Management: treat underlying disease, ACE inhibitor (enalapril/benazepril → reduce glomerular capillary pressure → reduce proteinuria), antiplatelet therapy (clopidogrel — hypercoagulable state), and dietary protein support.

Category 3: Lymphatic Oedema — When the Drains Are Blocked

The lymphatics are the body's 'overflow' system — they return filtered fluid, proteins, and cells from the interstitium to the circulation (via the thoracic duct → left subclavian vein). Lymph flow can increase 10–20× in response to increased filtration. When the lymphatics are obstructed or destroyed, interstitial fluid and protein accumulate → lymphoedema.

CHYLOTHORAX: The thoracic duct is the main lymphatic vessel draining the intestines, liver, and caudal body. When it is obstructed (neoplasia, heart disease, idiopathic) or ruptured (trauma), chyle — lymph rich in triglycerides and lymphocytes — accumulates in the pleural space. The fluid is milky-white (triglycerides >100 mg/dL, higher than serum), with a predominance of small lymphocytes. Management: thoracocentesis for respiratory distress, low-fat diet (reduces chyle flow), rutin (benzopyrone — stimulates lymphatic macrophage proteolysis), and in refractory cases, thoracic duct ligation + pericardectomy. CONGENITAL LYMPHOEDEMA: Hereditary failure of lymphatic development → accumulates in distal limbs from birth. Seen in certain dog breeds and in calves with Ayrshire lymphoedema.

Category 4: Permeability Oedema — When the Barrier Breaks Down

The endothelial glycocalyx — the 0.5–1 μm thick layer of proteoglycans, glycosaminoglycans (heparan sulfate, hyaluronan), and adsorbed plasma proteins on the luminal surface of the endothelium — is the primary determinant of capillary permeability. It sieves proteins: albumin and larger proteins are largely excluded from the sub-glycocalyx space, maintaining a low π_sg relative to π_c. When the glycocalyx is degraded, the capillary becomes permeable to protein → protein leaks into the interstitium → π_i rises → the oncotic gradient collapses → massive fluid extravasation → oedema. This is the mechanism of oedema in: sepsis (TNF-α, ROS, MMPs → glycocalyx shedding → capillary leak syndrome), acute pancreatitis (activated pancreatic enzymes → local endothelial injury → retroperitoneal and peritoneal fluid accumulation), anaphylaxis (histamine → endothelial contraction → gap formation between endothelial cells → increased permeability), and burns (direct thermal injury to endothelium → protein-rich oedema fluid).

Characteristically, permeability oedema is a HIGH-PROTEIN fluid (exudate: total protein >2.5–3.0 g/dL, nucleated cell count >3,000–5,000/μL) because the endothelial barrier is breached and proteins leak freely. This contrasts with hydrostatic and hypo-oncotic oedema, which produce TRANSUDATES (low protein, low cells). Fluid analysis (TP, cell count, cytology) is therefore a powerful diagnostic tool — it tells you WHY the fluid is there, not just THAT it is there.

Clinical Fluid Analysis and Classification in Practice

Thoracocentesis and Abdominocentesis: Analysing the Fluid

Fluid analysis is essential for classifying effusions and determining their aetiology. The minimum database for any effusion includes: total protein (by refractometer), nucleated cell count (by haemocytometer or automated counter), and cytological examination (direct smear or cytospin preparation, Diff-Quik or Wright's-Giemsa stain). Additional tests as indicated: triglyceride concentration (if chylous effusion suspected — pleural fluid triglycerides > serum triglycerides is diagnostic of chylothorax), creatinine (if uroabdomen suspected — abdominal fluid creatinine >2× serum creatinine), bilirubin (if biliary rupture suspected), and bacterial culture (aerobic and anaerobic) if septic effusion is suspected.

Special Topics: Cerebral Oedema and Pulmonary Oedema in Critical Care

Cerebral Oedema — Two Types, Two Treatments

CEREBRAL OEDEMA exists in two fundamentally different forms: (1) VASOGENIC OEDEMA — the blood-brain barrier (BBB) is breached → protein-rich fluid leaks from cerebral capillaries into the extracellular space of the brain. The BBB is maintained by tight junctions between cerebral endothelial cells, and its breakdown is driven by inflammation, trauma, or tumour-derived VEGF. Vasogenic oedema responds to CORTICOSTEROIDS (dexamethasone — stabilises the BBB, reduces VEGF expression) but NOT to osmotic agents (mannitol — because the BBB is breached, mannitol leaks into the brain parenchyma, drawing water with it and paradoxically worsening oedema). (2) CYTOTOXIC OEDEMA — cellular swelling (neurons, glia, endothelial cells) due to ATP depletion → failure of the Na⁺/K⁺-ATPase → intracellular Na⁺ accumulation → water influx → cell swelling. The BBB is INTACT. Cytotoxic oedema is the oedema of ischaemic stroke, traumatic brain injury, and hepatic encephalopathy. It responds to OSMOTIC AGENTS (mannitol 0.5–1 g/kg IV over 20 min, or hypertonic saline 3–7.5% — 4–5 mL/kg) because the intact BBB prevents these agents from entering the brain, creating an osmotic gradient that draws water out of swollen cells. Corticosteroids are INEFFECTIVE for cytotoxic oedema (and may worsen outcome in traumatic brain injury — the CRASH trial).

Reperfusion Pulmonary Oedema and ARDS

The acute respiratory distress syndrome (ARDS) is a permeability pulmonary oedema — diffuse alveolar-capillary membrane damage → protein-rich fluid floods the alveoli → severe hypoxaemia refractory to oxygen therapy. In veterinary patients, ARDS is triggered by: sepsis, severe pancreatitis, massive transfusion (TRALI — transfusion-related acute lung injury), near-drowning, smoke inhalation, and paraquat toxicity. The pathophysiology: activated neutrophils adhere to the pulmonary capillary endothelium → release of ROS, proteases, and inflammatory cytokines → endothelial and epithelial damage → increased permeability → alveolar flooding with protein-rich exudate → surfactant inactivation (plasma proteins inhibit surfactant) → alveolar collapse → ventilation-perfusion mismatch → hypoxaemia. The cornerstone of management is MECHANICAL VENTILATION with low tidal volumes (6–8 mL/kg — 'lung-protective ventilation') to prevent ventilator-induced lung injury. Furosemide is ineffective (this is NOT hydrostatic oedema). Corticosteroids are controversial. The mortality rate in veterinary ARDS is 60–80% — prevention (early recognition and treatment of the underlying trigger) is critical.

The Anatomy and Physiology of the Lymphatic System

Lymphatic Anatomy — A Second Circulation

The lymphatic system is the body's 'second circulation' — a low-pressure, unidirectional drainage network that returns interstitial fluid, proteins, and immune cells to the venous circulation. It begins as blind-ended lymphatic capillaries (initial lymphatics) in the tissues. These capillaries have: overlapping endothelial cells that function as ONE-WAY valves (increased interstitial pressure opens the gaps → fluid enters; increased intraluminal pressure closes them → fluid cannot leak back out), anchoring filaments that tether the endothelial cells to the surrounding extracellular matrix (preventing capillary collapse when interstitial pressure rises), and NO continuous basement membrane (unlike blood capillaries) — enabling uptake of large molecules and particles.

Lymph flows through progressively larger vessels → lymph nodes (filtration + immune surveillance) → lymphatic trunks → thoracic duct (the largest lymphatic vessel, running alongside the aorta in the caudal thorax) or right lymphatic duct → venous circulation at the junction of the internal jugular and subclavian veins (the 'venous angle'). Unlike the cardiovascular system, the lymphatic system has NO central pump — lymph flow is driven by: (1) SKELETAL MUSCLE CONTRACTION (the 'muscle pump' — compresses lymphatic vessels, and the one-way valves ensure unidirectional flow), (2) RESPIRATORY MOVEMENTS (changes in intrathoracic and intra-abdominal pressure), (3) SMOOTH MUSCLE in the walls of larger lymphatic vessels (spontaneous rhythmic contractions), and (4) ARTERIAL PULSATIONS transmitted from adjacent arteries. Lymph flow is therefore reduced by: immobility (hospitalised patients), increased central venous pressure (CHF → reduced pressure gradient for lymphatic drainage into the venous system), and lymphatic obstruction.

Chylothorax — When Lymph Becomes an Effusion

Chylothorax is the accumulation of chyle (lymph rich in triglycerides absorbed from the intestinal lacteals) in the pleural space. It occurs when the thoracic duct is obstructed or ruptured. In dogs, the commonest cause is IDIOPATHIC — likely a functional or structural abnormality of the thoracic duct itself (lymphangiectasia, abnormal collateralisation). Other causes: cranial mediastinal masses (lymphoma, thymoma) compressing the thoracic duct, heart disease (increased systemic venous pressure → reduced lymphatic drainage → lymph backs up and leaks from dilated thoracic lymphatics → chylothorax is a RARE manifestation of CHF in dogs, commoner in cats), trauma (rare — the thoracic duct heals rapidly), and lung lobe torsion (obstructing regional lymphatics). Diagnosis: pleural fluid triglycerides >100 mg/dL and > serum triglycerides. Fluid cytology: predominantly small lymphocytes in chronic cases; in acute or inflammatory cases, neutrophils may predominate. Management: (1) thoracocentesis as needed for respiratory distress, (2) low-fat diet (reduces chyle flow through the thoracic duct) + rutin (benzopyrone — stimulates proteolysis and macrophage activity in lymphatics), (3) if medical management fails: thoracic duct ligation + pericardectomy (creating a 'window' in the pericardium — thought to reduce back-pressure on the thoracic duct at its venous termination).

Cardiac Cachexia and Oedema in Right-Sided Heart Failure

The Paradox of Malnutrition with Fluid Overload

Patients with chronic right-sided CHF often present with a paradoxical combination: ASCITES and peripheral oedema (fluid overload) coexisting with MUSCLE WASTING and WEIGHT LOSS (cardiac cachexia). The mechanisms are multifactorial: (1) ANOREXIA — ascites causes abdominal distension → early satiety → reduced food intake. Additionally, inflammatory cytokines (TNF-α — originally named 'cachectin' for its role in wasting syndromes — is elevated in CHF) suppress appetite centrally. (2) MALABSORPTION — congested intestinal mucosa (from elevated systemic venous pressure → splanchnic congestion) absorbs nutrients poorly → chronic protein and caloric deficit. (3) INCREASED METABOLIC RATE — the failing heart and the respiratory muscles (working against pleural effusion or ascites-induced diaphragmatic compression) consume more energy. Additionally, systemic inflammation and sympathetic overactivation increase the basal metabolic rate by 10–20%. (4) PROTEIN-LOSING ENTEROPATHY — chronic hepatic and splanchnic congestion → lymphangiectasia → loss of protein-rich lymph into the GI lumen → hypoalbuminaemia → WORSENING oedema (now both hydrostatic AND hypo-oncotic) → a vicious cycle.

Management of cardiac cachexia: (1) Optimise CHF medications to reduce congestion. (2) Nutritional support — high-calorie, highly digestible diet; consider appetite stimulants (mirtazapine in cats, capromorelin in dogs — a ghrelin receptor agonist). (3) Omega-3 fatty acid supplementation (fish oil — EPA and DHA — reduce inflammatory cytokine production and have been shown to reduce cachexia in canine CHF in some studies). (4) Judicious use of diuretics — removing oedema fluid improves appetite and comfort but excessive diuresis → prerenal azotaemia and electrolyte disturbances. Cardiac cachexia carries a grave prognosis — it reflects end-stage CHF.

Non-Cardiogenic Ascites in Small Animals

When ascites is present without cardiomegaly, jugular distension, or other signs of right-sided CHF, consider: (1) HYPOALBUMINAEMIA (PLE, PLN, hepatic failure) — the commonest non-cardiac cause of pure/modified transudative ascites in dogs. (2) PORTAL HYPERTENSION — pre-hepatic (portal vein thrombosis), hepatic (cirrhosis — rare in dogs, common in humans; congenital portosystemic shunts typically do NOT cause ascites because they are low-pressure shunts), or post-hepatic (right-sided CHF, hepatic venous obstruction — Budd-Chiari syndrome, rare). (3) NEOPLASIA — carcinomatosis (diffuse peritoneal seeding of carcinoma — breast, pancreatic, gastric) → exudative ascites (increased capillary permeability + lymphatic obstruction). Cytology of the abdominal fluid may reveal neoplastic cells. (4) FELINE INFECTIOUS PERITONITIS (FIP) — the 'wet' form produces a characteristically high-protein (>3.5 g/dL), sticky, straw-coloured abdominal ± pleural effusion. The fluid is a pyogranulomatous exudate (high protein, moderate cellularity, macrophages and non-degenerate neutrophils). The Rivalta test is a useful point-of-care screening test: add a drop of effusion to acetic acid — if the drop retains its shape or forms a 'jellyfish' → positive (high protein content — consistent with FIP exudate). Definitive diagnosis: FCoV immunohistochemistry or RT-PCR on effusion macrophages.

Peripheral Oedema in Horses: The 'Stocking Up' Phenomenon and Beyond

Why Horses 'Stock Up' — Dependent Oedema in the Recumbent Horse

Horses commonly develop pitting oedema of the distal limbs — 'stocking up' — when confined to a stall or during prolonged transport. The mechanism is pure HYDROSTATIC OEDEMA: reduced skeletal muscle activity → reduced 'muscle pump' (which normally propels venous blood and lymph upward against gravity) → venous and lymphatic pooling in the dependent distal limbs → increased capillary hydrostatic pressure → transudation of fluid into the interstitium. The oedema is symmetrical, cold, non-painful, and pits on digital pressure. It resolves with exercise (walking — the muscle pump is reactivated → venous return increases → oedema fluid is returned to the circulation via lymphatics) or with elevation of the limbs. It does NOT require treatment — it is a benign, physiological response to inactivity.

When 'Stocking Up' Is NOT Benign — Pathological Oedema in the Horse

Asymmetrical or warm/painful limb oedema warrants immediate investigation: (1) CELLULITIS/LYMPHANGITIS — bacterial infection tracking along the lymphatics → hot, painful, rapidly progressive limb swelling ± fever, lameness. Common after wounds or punctures. The affected limb is markedly swollen, and serum may ooze from the skin ('weeping'). Treatment: systemic antibiotics (penicillin + gentamicin — broad-spectrum), NSAIDs (flunixin meglumine — analgesia + anti-inflammatory), cold-hosing, and hand-walking (promotes lymphatic drainage — DO NOT confine to a stall — movement is therapeutic). (2) PURPURA HAEMORRHAGICA — a type III hypersensitivity reaction (immune complex deposition) → vasculitis → subcutaneous oedema of the head, ventral abdomen, and limbs ± petechiae. Often follows strangles (Streptococcus equi) infection or vaccination. Treatment: corticosteroids (dexamethasone — immunosuppressive), NSAIDs, supportive care. (3) VENA CAVA SYNDROME — thrombosis or compression of the cranial or caudal vena cava → obstruction of venous return from the head/neck or caudal body → oedema and venous distension cranial or caudal to the obstruction. Cranial vena cava syndrome → oedema of the head, neck, and thoracic limbs. Caudal vena cava syndrome → oedema of the hind limbs and ventral abdomen. Causes: thoracic masses (lymphoma, thymoma), invasive mediastinal neoplasia, jugular vein thrombophlebitis extending into the cranial vena cava. Diagnosis: ultrasound (compression, thrombosis, or mass effect on the vena cava).

The key clinical distinction: BENIGN 'stocking up' is symmetric, cold, non-painful, pitting, and resolves with exercise. PATHOLOGICAL oedema is asymmetric, warm, painful, may be non-pitting (high-protein fluid or fibrosis), and does NOT resolve with exercise. When in doubt, ultrasound and laboratory evaluation (CBC, serum biochemistry, protein electrophoresis) are indicated.

Oedema in Exotic and Wildlife Species: Unique Considerations

Subcutaneous Oedema in Reptiles

Reptiles have a unique lymphatic system — they possess large, paired lymphatic sinuses (and in some species, 'lymph hearts' — contractile lymphatic vessels that actively pump lymph). Subcutaneous oedema in captive reptiles is common and may reflect: (1) hypoproteinaemia (malnutrition, chronic disease — reptiles have lower normal albumin than mammals, ~1.5–2.5 g/dL), (2) renal disease (reduced nitrogen excretion — uric acid is the primary nitrogenous waste; renal failure → hyperuricaemia → gout and oedema), (3) cardiac disease (relatively rare in reptiles but well-described in older individuals), (4) iatrogenic fluid overload (reptiles have a low metabolic rate and absorb subcutaneous fluids slowly — SC fluids are commonly administered in the prefemoral or axillary regions, and overzealous administration → localised oedema), (5) hypocalcaemia (nutritional secondary hyperparathyroidism — common in captive insectivorous and herbivorous reptiles with inadequate UVB/calcium → increased vascular permeability?), and (6) cellulitis/abscessation (reptiles produce caseous, inspissated pus — not liquid — so the swelling is firm rather than fluctuant).

Oedema in avian species follows similar principles to mammals, with the important caveat that birds have a RENAL PORTAL SYSTEM — blood from the hind limbs and caudal body passes through the kidney before returning to the heart. This means that hind-limb oedema may result from renal disease (impaired venous drainage through the renal portal system) as well as from cardiac or hypoproteinaemic causes. Additionally, birds have very thin skin with minimal subcutaneous tissue — oedema is often visible through the skin as a translucent, fluid-filled swelling. In poultry, 'breast blister' (sternal bursitis) is a form of localised pressure oedema and inflammation from prolonged contact with hard or wet flooring — it is prevented by appropriate husbandry and substrate management.

Frequently asked questions

Self-check quiz

Test yourself. Answers are below each question — cover them first if you are studying.